In this episode, Ryan Severson and Victoria Hamscho discuss recent developments in pharmaceutical pricing and the 340B Drug Pricing Program heading into 2020, including reimbursement cuts for 340B drugs under the Outpatient Prospective Payment System and the ongoing litigation challenging the cuts, 340B state action on discriminatory pricing, drug pricing reform, International Pricing Index and Safe Drug Importation Action Plan, and pharmacists’ provider status under Medicare.

Presenters: Ryan Severson, Victoria Hamscho

Download Presentation Materials

Podden och tillhörande omslagsbild på den här sidan tillhör K&L Gates. Innehållet i podden är skapat av K&L Gates och inte av, eller tillsammans med, Poddtoppen.